# Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

> **NCT02363647** · NA · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 10 (actual)

## Conditions studied

- Medullary Thyroid Cancer
- Colon Cancer

## Interventions

- **OTHER:** Tumor Genomic Analysis

## Key facts

- **NCT ID:** NCT02363647
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2022-08
- **Final completion:** 2022-08
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** No Current Funding
- **Last updated:** 2022-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02363647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02363647, "Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02363647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*